How much funding has Ona Therapeutics raised?

Ona Therapeutics has raised $152.1M in total funding, most recently a Series B round.

Who are Ona Therapeutics's investors?

Ona Therapeutics's investors include Asabys Partners, Ysios Capital, Alta Life Sciences, Bpifrance, Forbion Capital Partners, European venture capital.

When was Ona Therapeutics founded?

Ona Therapeutics was founded in 2019.

Where is Ona Therapeutics headquartered?

Ona Therapeutics is headquartered in Barcelona, United States.

What industry is Ona Therapeutics in?

Ona Therapeutics operates in Biotech, Healthcare.

How many employees does Ona Therapeutics have?

Ona Therapeutics has 11-50 employees.

Ona Therapeutics

First-in-class ADCs tailored to attack advanced cancer.

Barcelona, United States · Founded 2019 · $152.1M raised

Biotech

Healthcare

Headquarters: Barcelona
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: ona-therapeutics.com
Total Funding: $152.1M
Last Round: $86.6M Series BJun 2026
Rounds: 4

About

Ona Therapeutics is a Barcelona-based biotech spun out of ICREA and IRB Barcelona, pioneering first-in-class antibody drug conjugates (ADCs) for advanced, treatment-refractory cancers. The company identifies novel therapeutic targets from real-world refractory patient samples.

Summary

Ona Therapeutics is a Biotech company based in Barcelona, United States, founded in 2019. It has raised $152.1M in total across 4 rounds, most recently a $86.6M Series B round in Jun 2026. Investors include Asabys Partners, Ysios Capital and Alta Life Sciences.

LinkedIn X (Twitter)